Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 20599581)

1.

Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression.

Maes M.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Apr 29;35(3):664-75. doi: 10.1016/j.pnpbp.2010.06.014. Epub 2010 Jun 20. Review.

PMID:
20599581
2.
3.
6.

In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression.

Kubera M, Obuchowicz E, Goehler L, Brzeszcz J, Maes M.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Apr 29;35(3):744-59. doi: 10.1016/j.pnpbp.2010.08.026. Epub 2010 Sep 7. Review.

PMID:
20828592
7.

Inflammatory and neurodegenerative pathways in depression: a new avenue for antidepressant development?

Catena-Dell'Osso M, Bellantuono C, Consoli G, Baroni S, Rotella F, Marazziti D.

Curr Med Chem. 2011;18(2):245-55. Review.

PMID:
21110802
8.

Increased autoimmune activity against 5-HT: a key component of depression that is associated with inflammation and activation of cell-mediated immunity, and with severity and staging of depression.

Maes M, Ringel K, Kubera M, Berk M, Rybakowski J.

J Affect Disord. 2012 Feb;136(3):386-92. doi: 10.1016/j.jad.2011.11.016. Epub 2011 Dec 12.

PMID:
22166399
9.

Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression.

Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H.

Cytokine. 1997 Nov;9(11):853-8.

PMID:
9367546
11.
13.

Activation of cell-mediated immunity in depression: association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression.

Maes M, Mihaylova I, Kubera M, Ringel K.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Jan 10;36(1):169-75. doi: 10.1016/j.pnpbp.2011.09.006. Epub 2011 Sep 16.

PMID:
21945535
14.

Association between increased tryptophan degradation and depression in cancer patients.

Kurz K, Schroecksnadel S, Weiss G, Fuchs D.

Curr Opin Clin Nutr Metab Care. 2011 Jan;14(1):49-56. doi: 10.1097/MCO.0b013e328340d849. Review.

PMID:
21076293
15.

Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms.

Bonaccorso S, Puzella A, Marino V, Pasquini M, Biondi M, Artini M, Almerighi C, Levrero M, Egyed B, Bosmans E, Meltzer HY, Maes M.

Psychiatry Res. 2001 Dec 15;105(1-2):45-55.

PMID:
11740974
18.

New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Maes M, Fišar Z, Medina M, Scapagnini G, Nowak G, Berk M.

Inflammopharmacology. 2012 Jun;20(3):127-50. doi: 10.1007/s10787-011-0111-7. Epub 2012 Jan 24. Review.

PMID:
22271002
19.

Circulating levels of cytokines and soluble cytokine receptors in various T-cell malignancies.

Raziuddin S, Sheikha A, Abu-Eshy S, al-Janadi M.

Cancer. 1994 May 1;73(9):2426-31.

PMID:
8168046
20.

Examining a paradox in the pathogenesis of human pulmonary tuberculosis: immune activation and suppression/anergy.

Vanham G, Toossi Z, Hirsch CS, Wallis RS, Schwander SK, Rich EA, Ellner JJ.

Tuber Lung Dis. 1997;78(3-4):145-58. Review.

PMID:
9713647
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk